Phillip G. Febbo, Chief Scientific & Med Officer at VERACYTE, INC. (VCYT), sold 7,868 shares at $44.09 ($347K) on 2024-12-04, disclosed to the SEC on 2024-12-06.
Scheduled sale ($347k) by Chief Scientific & Med Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $44.09 | 3,934 | $173K | 50.0% |
| 2 | $44.09 | 3,934 | $173K | 50.0% |
| Total | $44.09 avg | 7,868 | $347K | 100% |
| Filing → |
| VCYT | SELL | 2025-10-07 | $601K | — | Filing → |
| VCYT | SELL | 2025-03-06 | $536K | — | Filing → |
| ILMN | SELL | 2022-04-07 | $1.4M | — | Filing → |